A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...

Bi-Specific 3rd Generation CAR T therapy is a revolutionary advancement in cellular immunotherapy, primarily used to treat ...

Marker has advanced its manufacturing technology, reducing overall manufacturing time to nine days and generating a product with higher potency due to improved T cell composition and specificity.

For decades, dogma dictated that the immune system consisted of two separate branches. Cells of the innate system respond rapidly to molecular patterns shared by a broad array of pathogens. Meanwhile, ...

In patients with PD, neurons or nerve cells in the brain can’t produce enough of a chemical ... As a result, this work has the potential to not only provide a marker to diagnose PD earlier, but also ...

Dr. Yang Jian, leader of the team that published the Nature article unveiling a new method known simply as "gsMap" Photo: ...

An AI-based computer model makes aging visible at the cellular level for the first time. Researchers have applied it to ...

will present at the H.C. Wainwright 3 rd Annual Cell Therapy Virtual Conference. This virtual investor event will be held on February 25, 2025. Dr. Vera will present an overview of Marker’s technology ...

They may also be a useful diagnostic marker when creating treatment plans. Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.